• Starter AI
  • Posts
  • Introducing: Stable Video 3D, GitHub’s Autofix, Insilico's AI breakthroughs

Introducing: Stable Video 3D, GitHub’s Autofix, Insilico's AI breakthroughs

A helping hand for developers!

Hello, Starters!

AI's constant development is set to transform numerous fields. Medicine, robotics, and computer engineering are just a few examples. Can you think of any others?

Here’s what you’ll find today:

  • Stability AI presents Stable Video 3D

  • GitHub’s new code-scanning tool

  • Inside Insilico Medicine’s drug discovery journey

  • Novo Nordisk’s upcoming AI supercomputer

  • Neuralink's brain-chip patient progress

  • And more.

Well-known for their generative AI models, Stability AI has recently unveiled Stable Video 3D. This model, based on Stable Video Diffusion, can create 3D content from a single frame, potentially enhancing media creators' processes in areas such as animation, VR, and game design.

The model has two variants: SV3D_u, which generates orbital videos from single images without camera conditioning, and SV3D_p, which expands on this by accommodating both single images and orbital views, thereby creating 3D videos along specified camera paths.

Despite undergoing major changes, with key researchers bidding farewell to the startup, Stability AI continues to thrive on the scene with its open AI models for image, video, audio, language, and now 3D.

GitHub has announced "Code scanning autofix" for its Advanced Security customers, providing tools to enhance developers' workflows. This tool detects vulnerabilities in the coding process and suggests changes to multiple files or necessary dependencies, minimising the efforts most developers go through during remediation. 

Powered by GitHub Copilot and CodeQL, code scanning autofix supports JavaScript, TypeScript, Java, and Python.

Insilico Medicine is a biotechnology company with a plan to create the first AI-based drug for fatal lung conditions. Through its software, the company has leveraged AI to determine which targets within the cell to interact with and what the chemical structure of the drug should be.

Its CEO, Alex Zhavoronkov, has worked with AI for years and hopes that its constant development can enable scientists to find cures and new treatments for diseases as easily as asking a chatbot. There is no doubt that biology will be the focus of the next AI revolution.

🧑‍⚕️Novo Nordisk, a Danish pharmaceutical company, has announced that they're harnessing Nvidia's technologies to develop "Gefion," an AI supercomputer aimed at accelerating research in drug discovery, disease diagnosis, and treatment.

🧠Neuralink, Elon Musk's neurotech company, has shared updates on the progress of the first human patient with their brain implant during a live video on X. Noland Arbaugh, the patient, has showcased significant development and can be seen moving a mouse and playing chess on a computer.

What did you think of today's newsletter?

Login or Subscribe to participate in polls.

Thank you for reading!